Data protection Impressum

Newsroom

From left to right: Nicolas Weber, CEO of Voltiris, Nasri Nahas, CEO of Biopôle SA, Jonas Roch, CTO of Voltiris and Pierre-Jean Wipff, Innovation and Partnerships Director at Biopôle.

Business environment

Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund

11 October 2023

Sparta Commodities’ solution represents a paradigm of future-oriented, real-time market insights that elevates commodity trading to novel heights.

USD 17.5 million to expand Sparta’s intelligent commodity trading solution globally

11 October 2023

Adiposs pioneers a new era in cancer patient care with a pivotal leap towards making ImageBAT a revolutionary tool in detecting hypermetabolism.

Adiposs completes the phase I clinical trial of its flagship product ImageBAT

11 October 2023

Impaakt has raised nearly USD 8 million, underscoring its robust journey in democratizing sustainability data and impact assessment.

Geneva fintech Impaakt secures USD 8 million to transform sustainability

11 October 2023

PULSE, with its distinctive amalgamation of adaptable, future-proof infrastructure, is set to become a pivotal hub designed to uplift and expand the frontiers of biotech and various scientific ventures.

PULSE, a modular innovation center in the heart of the Health Valley

10 October 2023

Through this partnership, the synergy between academic excellence and pioneering biotherapeutic research is set to delineate new horizons in patient care, particularly in the field of tissue regeneration and repair.

Orio Therapeutics partners with Australia’s largest University to transform regenerative medicine

10 October 2023

Located within the Geneva University Hospitals (HUG) complex, the SFITS has firmly rooted itself in pioneering surgical training and innovation in Switzerland. | © SFITS

SFITS, the Swiss Foundation for Innovation and Training in Surgery

Lonza continues to fortify its position in ADC production, expanding collaboration and infrastructure to enhance its acclaimed Ibex Dedicate Biopark.

Lonza further extends its ADC manufacturing capabilities in Visp

9 October 2023

Join me on my European adventure (Blog #1 by Jimmy Jackson)

Join me on my European adventure (Part #1 by Jimmy Jackson)

4 October 2023

The Institute of Life Technologies of the HES-SO Valais/Wallis has forged a five-year collaboration with Debiopharm Research & Manufacturing to develop new targeted antibody fragment vectorization technologies.

HES-SO Valais-Wallis and Debiopharm partner up to battle cancer

4 October 2023

1 … 49 50 51 52 53 54 55 56 57 … 141